STOCKHOLM — Trial results are demonstrating the safety and effectiveness of a novel gene modifier therapy for treating retinitis pigmentosa associated with NR2E3 and RHO mutations. Researchers ...

Two new compounds may be able to treat retinitis pigmentosa, a group of inherited eye diseases that cause blindness. The compounds were identified using a virtual screening approach. Two new compounds ...

Scientists believe they have discovered a special antibody which may lead to a treatment for Retinitis Pigmentosa, a condition that causes loss of central vision, as well as night and color vision. A ...

Retinitis Pigmentosa: Symptoms, Causes, Diagnosis and Treatment: By Shreoshree Chakrabarty Retinitis pigmentosa (RP) is a group of rare genetic eye disorders that cause progressive vision loss due to ...

Please provide your email address to receive an email when new articles are posted on . MCO-010, a mutation-agnostic gene therapy, demonstrated vision improvement in retinitis pigmentosa. Nanoscope ...

Chitra Kannabiran, PhD, Kallam Anji Reddy Molecular Genetics Laboratory, Hyderabad Eye Research Foundation, Champalimaud Translational Centre, LV Prasad Eye Institute, Hyderabad 500 034, India ...

This story is part of a series on the current progression in Regenerative Medicine. This piece is part of a series dedicated to the eye and improvements in restoring vision. In 1999, I defined ...

PYC Therapeutics Limited (AU:PYC) has released an update. PYC Therapeutics has announced positive results from its ongoing clinical trials for VP-001, a treatment for the childhood blinding disease ...

The trial is funded through Abu Dhabi’s Healthcare Research and Innovation Fund Clinical development activities will commence at Cleveland Clinic Abu Dhabi in 2026 MERTK-related retinitis pigmentosa ...

Retinitis pigmentosa (RP) is a group of rare genetic diseases that affect the light-sensitive part of the eye, called the retina. “Atypical RP” refers to RP that lacks the characteristic features of ...

Treatment with bioavailable small-molecule pharmacochaperones targeting the visual receptor rhodopsin offers a promising approach to prevent retinal photoreceptor degeneration caused by inherited ...